Sovaldi

Gilead Sciences is an American biotechnology company holding the patent for drug Remdesivir for treating various Coronavirus in over 70 countries. The company has secured orphan drug status for Remdesivir, allowing it to exclusively obtain marketing revenues for up to 7 years. However, behind the benign image of a vaccine